Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli

Neuroscience

Volumn 118, Issue 4, 2003, Pages 1045-1053

  Zhu, L L ^a,b   Onaka, T ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

ACTH; Emotional stress; Freezing behavior; Nucleus tractus solitarius; Rat; Ventrolateral medulla

Indexed keywords

GENE PRODUCT; MONOCLONAL ANTIBODY; OXYTOCIN; PROLACTIN RELEASING FACTOR; PROLACTIN RELEASING PEPTIDE ANTIBODY; PROTEIN FOS; TRACER; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONDITIONING; CONTROLLED STUDY; CORTICOTROPIN RELEASE; EMOTIONAL STRESS; FEAR; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STIMULUS; SUPRAOPTIC NUCLEUS;

EID: 0038743051     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00059-9     Document Type: Article

References (66)

1. Bealer S.L., Crowley W.R. Noradrenergic control of central oxytocin release during lactation in rats. Am J Physiol. 274:1998;E453-E458.
2. Bernardis L.L., Bellinger L.L. The dorsomedial hypothalamic nucleus revisited 1998 update . Proc Soc Exp Biol Med. 218:1998;284-306.
3. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol. 81:1972;281-290.
4. Ceccatelli S., Villar M.J., Goldstein M., Hokfelt T. Expression of c-Fos immunoreactivity in transmitter characterized neurons after stress. Proc Natl Acad Sci USA. 86:1989;9569-9573.
5. Chen C.T., Dun S.L., Dun N.J., Chang J.K. Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res. 822:1999;276-279.
6. Crowley W.R., Armstrong W.E. Neurochemical regulation of oxytocin secretion in lactation. Endocr Rev. 13:1992;33-65.
7. Davis M (2000) The role of the amygdala in conditioned and unconditioned fear and anxiety. In: The amygdala (Aggleton JP, ed), pp 213-288. Oxford: Oxford University Press.
8. Dayas C.V., Buller K.M., Day T.A. Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor. Neuroscience. 105:2001;707-719.
9. Dayas C.V., Day T.A. Opposing roles for medial and central amygdala in the initiation of noradrenergic cell responses to a psychological stressor. Eur J Neurosci. 15:2002;1712-1718.
10. Douglas A.J., Scullion S., Antonijevic I.A., Brown D., Russell J.A., Leng G. Uterine contractile activity stimulates supraoptic neurons in term pregnant rats via a noradrenergic pathway. Endocrinology. 142:2001;633-644.
11. Ellacott K.L., Lawrence C.B., Rothwell N.J., Luckman S.M. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology. 143:2002;368-374.
12. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci. 14:1994;897-913.
13. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev. 23:1999;743-760.
14. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin structure, function, and regulation of secretion . Physiol Rev. 80:2000;1523-1631.
15. Gimpl G., Fahrenholz F. The oxytocin receptor system structure, function, and regulation . Physiol Rev. 81:2001;629-683.
16. Higuchi T., Honda K., Fukuoka T., Negoro H., Wakabayashi K. Release of oxytocin during suckling and parturition in the rat. J Endocrinol. 105:1985;339-346.
17. Higuchi T., Honda K., Takano S., Negoro H. Reduced oxytocin response to osmotic stimulus and immobilization stress in lactating rats. J Endocrinol. 116:1988;225-230.
18. Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoyo M., Fukusumi S., Kitada C., Masuo Y., Asano T., Matsumoto H., Sekiguchi M., Kurokawa T., Nishimura O., Onda H., Fujino M. A prolactin-releasing peptide in the brain. Nature. 393:1998;272-276.
19. Ibata Y., Iijima N., Kataoka Y., Kakihara K., Tanaka M., Hosoya M., Hinuma S. Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain. Neurosci Res. 38:2000;223-230.
20. Iijima N., Kataoka Y., Kakihara K., Bamba H., Tamada Y., Hayashi S., Matsuda T., Tanaka M., Honjyo H., Hosoya M., Hinuma S., Ibata Y. Cytochemical study of prolactin-releasing peptide (PrRP) in the rat brain. Neuroreport. 10:1999;1713-1716.
21. Lachuer J., Gaillet S., Barbagli B., Buda M., Tappaz M. Differential early time course activation of the brainstem catecholaminergic groups in response to various stresses. Neuroendocrinology. 53:1991;589-596.
22. Lang R.E., Heil J.W., Ganten D., Hermann K., Unger T., Rascher W. Oxytocin unlike vasopression is a stress hormone in the rat. Neuroendocrinology. 37:1983;314-316.
23. Lawrence C.B., Ellacott K.L.J., Luckman S.M. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology. 143:2002;360-367.
24. Lawrence C.B., Celsi F., Brennand J., Luckman S.M. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci. 3:2000;645-646.
25. LeDoux J (2000) The amygdala and emotion: a view through fear. In: The amygdala (Aggleton JP, ed), pp 289-310. Oxford: Oxford University Press.
26. Legros J.J. Inhibitory effect of oxytocin on corticotrope function in humans are vasopressin and oxytocin ying-yang neurohormones? Psychoneuroendocrinology. 26:2001;649-655.
27. Leng G., Brown C.H., Russell J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol. 57:1999;625-655.
28. Luckman S.M. Fos-like immunoreactivity in the brainstem of the rat following peripheral administration of cholecystokinin. J Neuroendocrinol. 4:1992;149-152.
29. Luckman S.M. Fos expression within regions of the preoptic area, hypothalamus and brainstem during pregnancy and parturition. Brain Res. 669:1995;115-124.
30. Maruyama M., Matsumoto H., Fujiwara K., Kitada C., Hinuma S., Onda H., Fujino M., Inoue K. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology. 140:1999;2326-2333.
31. Maruyama M., Matsumoto H., Fujiwara K., Noguchi J., Kitada C., Fujino M., Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology. 142:2001;2032-2038.
32. Maruyama M., Matsumoto H., Fujiwara K., Noguchi J., Kitada C., Hinuma S., Onda H., Nishimura O., Fujino M., Higuchi T., Inoue K. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci Lett. 276:1999;193-196.
33. Matsumoto H., Maruyama M., Noguchi J., Horikoshi Y., Fujiwara K., Kitada C., Hinuma S., Onda H., Nishimura O., Inoue K., Fujino M. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett. 285:2000;234-238.
34. Meddle S.L., Leng G., Selvarajah J.R., Bicknell R.J., Russell J.A. Direct pathways to the supraoptic nucleus from the brainstem and the main olfactory bulb are activated at parturition in the rat. Neuroscience. 101:2000;1013-1021.
35. Morales T., Hinuma S., Sawchenko P.E. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurones. J Neuroendocrinol. 12:2000;131-140.
36. Murphy N.P., Onaka T., Brown C.H., Leng G. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat. Neuroscience. 80:1997;567-577.
37. Neumann I.D., Wigger A., Torner L., Holsboer F., Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats partial action within the paraventricular nucleus . J Neuroendocrinol. 12:2000;235-243.
38. Nishioka T., Anselmo-Franci J.A., Li P., Callahan M.F., Morris M. Stress increases oxytocin release within the hypothalamic paraventricular nucleus. Brain Res. 781:1998;56-60.
39. Onaka T. Catecholaminergic mechanisms underlying neurohypophysial hormone responses to unconditioned or conditioned aversive stimuli in rats. Exp Physiol. 85S:2000;101S-110S.
40. Onaka T., Luckman S.M., Antonijevic I., Palmer J.R., Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience. 66:1995;403-412.
41. Onaka T., Palmer J.R., Yagi K. Norepinephrine depletion impairs neuroendocrine responses to fear but not novel environmental stimuli in the rat. Brain Res. 713:1996;261-268.
42. Onaka T., Yagi K. Differential effects of naloxone on neuroendocrine responses to fear-related emotional stress. Exp Brain Res. 81:1990;53-58.
43. Onaka T., Yagi K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats. Brain Res. 788:1998;287-293.
44. Onaka T., Yagi K. Involvement of N-methyl-D-aspartic acid receptor activation in oxytocin and vasopressin release after osmotic stimuli in rats. J Neuroendocrinol. 13:2001;166-174.
45. Onaka T., Yagi K., Hamamura M. Vasopressin secretion suppression after light and tone stimuli previously paired with footshocks in rats . Exp Brain Res. 71:1988;291-297.
46. Onaka T., Yamashita T., Liu X., Honda K., Saito T., Yagi K. Medullary A1 noradrenergic neurones may mediate oxytocin release after noxious stimuli. Neuroreport. 12:2001;2499-2502.
47. Pacák K., Palkovits M. Stressor specificity of central neuroendocrine responses implications for stress-related disorders . Endocr Rev. 22:2001;502-548.
48. Peterson M. Cardiovascular effects of oxytocin. Prog Brain Res. 139:2002;281-288.
49. Pezzone M.A., Lee W.-S., Hoffman G.E., Pezzone K.M., Rabin B.S. Activation of brainstem catecholaminergic neurons by conditioned and unconditioned aversive stimuli as revealed by c-Fos immunoreactivity. Brain Res. 608:1993;310-318.
50. Pitkänen A (2000) Connectivity of the rat amygdaloid complex. In: The amygdala (Aggleton JP, ed), pp 31-115. Oxford: Oxford University Press.
51. Rinaman L., Verbalis J.G., Stricker E.M., Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J Comp Neurol. 338:1993;475-490.
52. Robinson D.A., Wei F., Wang G.D., Li P., Kim S.J., Vogt S.K., Muglia L.J., Zhuo M. Oxytocin mediates stress-induced analgesia in adult mice. J Physiol. 540:2002;593-606.
53. Roland B.L., Sutton S.W., Wilson S.J., Luo L., Pyati J., Huvar R., Erlander M.G., Lovenberg T.W. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology. 140:1999;5736-5745.
54. Romero L.M., Sapolsky R.M. Patterns of ACTH secretagog secretion in response to psychological stimuli. J Neuroendocrinol. 8:1996;243-258.
55. Samson W.K., Resch Z.T., Murphy T.C. A novel action of the newly described prolactin-releasing peptides cardiovascular regulation . Brain Res. 858:2000;19-25.
56. 1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus. Neuroscience. 91:1999;639-649.
57. Sawchenko P.E., Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev. 4:1982;275-325.
58. Seal L.J., Small C.J., Dhillo W.S., Stanley S.A., Abbott C.R., Ghatei M.A., Bloom S.R. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology. 142:2001;4236-4243.
59. Smith D.W., Day T.A. c-Fos expression in hypothalamic neurosecretory and brainstem catecholamine cells following noxious somatic stimuli. Neuroscience. 58:1994;765-775.
60. Stoehr J.D., Cramer C.P., North W.G. Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behaviour. Psychoneuroendocrinology. 17:1992;267-271.
61. Tanaka M., Yoshida M., Emoto H., Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety basic studies . Eur J Pharmacol. 405:2000;397-406.
62. Thiele T.E., Cubero I., van Dijk G., Mediavilla C., Bernstein I.L. Ethanol-induced c-fos expression in catecholamine- and neuropeptide Y-producing neurons in rat brainstem. Alcohol Clin Exp Res. 24:2000;802-809.
63. Uvnäs-Moberg K. Antistress pattern induced by oxytocin. News Physiol Sci. 13:1998;22-26.
64. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress new insights into the secretory capacities of peptidergic neurons . Neuroscience. 85:1998;1209-1222.
65. Zhu L.L., Onaka T. Involvement of medullary A2 noradrenergic neurons in the activation of oxytocin neurons after conditioned-fear stimuli. Eur J Neurosci. 16:2002;2186-2198.
66. Zou C.-J., Onaka T., Yagi K. Role of adrenoceptors in vasopressin, oxytocin and prolactin responses to conditioned fear stimuli. J Neuroendocrinol. 10:1998;905-910.